A Cost-Effectiveness Analysis to Illustrate the Impact of Cost Definitions on Results, Interpretations and Comparability of Pharmacoeconomic Studies in the US

Author： Tunis Sandra L.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.27, Iss.9, 2009-09, pp. : 735-744

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost–effectiveness analysis in pharmacogenomics

By Payne Katherine   Shabaruddin Fatiha H  

Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. : 643-646

Future Medicine

Access to resources Recommend Favorite

Estimating `Costs' for Cost-Effectiveness Analysis

By Miners Alec  

PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. : 745-751

Adis International

Access to resources Recommend Favorite

Subgroups and Heterogeneity in Cost-Effectiveness Analysis

By Sculpher Mark  

PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. : 799-806

Adis International

Access to resources Recommend Favorite

Exploring Uncertainty in Cost-Effectiveness Analysis

By Claxton Karl  

PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. : 781-798

Adis International

Access to resources Recommend Favorite

Sensitivity Analysis in Cost-Effectiveness Studies: From Guidelines to Practice

By Jain Rahul  

PharmacoEconomics, Vol. 29, Iss. 4, 2011-04 ,pp. : 297-314

Adis International

Access to resources Recommend Favorite